Integra Lifesciences is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately of sales internationally, with the remainder derived from the United States.
| Website: | www.integralife.com |
| Email: | michael.beaulieu@integralife.com |
| Main Phone: | +1 609 275-0500 |
| Address: | 1100 Campus Road |
| State: | NJ |
| City / Town: | Princeton |
| Country: | USA |
| Postal Code: | 08540 |
| Exchange: | NGS |
| CEO: | Peter J. Arduini |
| Employees: | 4000 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
Growth this year is expected to be driven by the acquisition of Codman Neurosurgery, the launch of new products, and investments in expanded sales channels.
Integra is also moving the needle on revenue and EPS growth from its recent M&A deals.
Nonfarm payrolls rose by 200,000 in December with the Unemployment Rate down a notch to 8.5%. The labor force participation rate remained low at 64.0%. The Dow Jones Industrial Average opened
The United States Department of Labor's monthly job report was released today and included what many are interpreting as very positive news regarding the economy. The nation added 200,000 jobs in
The Chicago PMI came in at 58.4 in October slightly below consensus. The Dow Jones Industrial Average traded down from 12,229.29 towards 12,000 going into the final half hour of trading. The
Integra Lifesciences is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and orthopedics and tissue technologies. Codman specialty surgical generates maximum revenue from its segmental operations. Integra earns approximately of sales internationally, with the remainder derived from the United States.
| Website: | www.integralife.com |
| Email: | michael.beaulieu@integralife.com |
| Main Phone: | +1 609 275-0500 |
| Address: | 1100 Campus Road |
| State: | NJ |
| City / Town: | Princeton |
| Country: | USA |
| Postal Code: | 08540 |
| Exchange: | NGS |
| CEO: | Peter J. Arduini |
| Employees: | 4000 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
Growth this year is expected to be driven by the acquisition of Codman Neurosurgery, the launch of new products, and investments in expanded sales channels.
Integra is also moving the needle on revenue and EPS growth from its recent M&A deals.
Nonfarm payrolls rose by 200,000 in December with the Unemployment Rate down a notch to 8.5%. The labor force participation rate remained low at 64.0%. The Dow Jones Industrial Average opened
The United States Department of Labor's monthly job report was released today and included what many are interpreting as very positive news regarding the economy. The nation added 200,000 jobs in
The Chicago PMI came in at 58.4 in October slightly below consensus. The Dow Jones Industrial Average traded down from 12,229.29 towards 12,000 going into the final half hour of trading. The
| Last Price 48.72 | Change $ 0.07 | Change % 0.14 | Tick N/A |
| Bid 40.46 | Bid Size 600.00 | Ask 52.37 | Ask Size 500.00 |
| Open 49.35 | High 49.81 | Low 48.60 | Prev Close 48.65 |
| Last Trade | Volume 526,759 | 52 Wk Hi 65.09 | 52 Wk Low 34.21 |
| Market Cap 4.1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 84,843,053.00 | EPS (TTM) 0.31 | PE Ratio 157.20 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 39 | 158 |
| Number of Buys | 14 | 69 |
| Number of Sells | 25 | 89 |
| Net Activity | 5597 | 81130 |
| Last 10 Buys | Shares |
|---|---|
| Barbara B. Hill | 1,000 |
| Donald E. Morel | 1,000 |
| Donald E. Morel | 1,000 |
| Barbara B. Hill | 1,000 |
| Richard E. Caruso | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Daniel L. Reuvers | 1,000 |
| Glenn Coleman | 1,000 |
| Glenn Coleman | 1,000 |
| Joseph Vinhais | 1,000 |
| Richard E. Caruso | 1,000 |
| Richard E. Caruso | 1,000 |
| James M. Sullivan | 1,000 |
| Christian S. Schade | 1,000 |
| Keith Bradley | 1,000 |
| Jeffrey Mosebrook | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 74 | 70 | 70 | 74 |
| Low Target Price Estimate | 50 | 50 | 50 | 50 |
| Mean Target Price Estimate | 61.73 | 61.36 | 61.36 | 61.73 |
| Standard Deviation | 6.56 | 5.89 | 5.89 | 6.56 |
| Date of Most Recent Estimate | 06/01/18 | 05/22/18 | 05/22/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| SD | Specialized Disclosure Report | 5 | 2018-05-31 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-24 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 9 | 9 | 9 | 8 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.38 | 2.38 | 2.38 | 2.33 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait